 |
PDBsum entry 5er2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
5er2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.23.22
- endothiapepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity similar to that of pepsin A, preferring hydrophobic residues at P1 and P1', but does not cleave 14-Ala-|-Leu-15 in the B chain of insulin or Z-Glu-Tyr. Clots milk.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Embo J
8:2179-2188
(1989)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.
|
|
A.Sali,
B.Veerapandian,
J.B.Cooper,
S.I.Foundling,
D.J.Hoover,
T.L.Blundell.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The conformation of the synthetic renin inhibitor CP-69,799, bound to the active
site of the fungal aspartic proteinase endothiapepsin (EC 3.4.23.6), has been
determined by X-ray diffraction at 1.8 A resolution and refined to the
crystallographic R factor of 16%. CP-69,799 is an oligopeptide transition--state
analogue inhibitor that contains a new dipeptide isostere at the P1-P1'
position. This dipeptide isostere is a nitrogen analogue of the well-explored
hydroxyethylene dipeptide isostere, wherein the tetrahedral P1' C alpha atom has
been replaced by trigonal nitrogen. The inhibitor binds in the extended
conformation, filling S4 to S3' pockets, with hydroxyl group of the P1 residue
positioned symmetrically between the two catalytic aspartates of the enzyme.
Interactions between the inhibitor and the enzyme include 12 hydrogen bonds and
extensive van der Waals contacts in all the pockets, except for S3'. The crystal
structure reveals a bifurcated orientation of the P2 histidine side chain and an
interesting relative rotation of the P3 phenyl ring to accommodate the
cyclohexyl side chain at P1. The binding of the inhibitor to the enzyme, while
producing no large distortions in the enzyme active site cleft, results in small
but significant change in the relative orientation of the two endothiapepsin
domains. This structural change may represent the action effected by the
proteinase as it distorts its substrate towards the transition state for
proteolytic cleavage.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.O.Badasso,
V.Dhanaraj,
S.P.Wood,
J.B.Cooper,
and
T.L.Blundell
(2004).
Crystallization and X-ray analysis of the Y75N mutant of Mucor pusillus pepsin complexed with inhibitor.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
770-772.
|
 |
|
|
|
|
 |
M.Shatsky,
R.Nussinov,
and
H.J.Wolfson
(2004).
FlexProt: alignment of flexible protein structures without a predefinition of hinge regions.
|
| |
J Comput Biol,
11,
83.
|
 |
|
|
|
|
 |
N.S.Andreeva,
and
L.D.Rumsh
(2001).
Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.
|
| |
Protein Sci,
10,
2439-2450.
|
 |
|
|
|
|
 |
N.Sinha,
S.Kumar,
and
R.Nussinov
(2001).
Interdomain interactions in hinge-bending transitions.
|
| |
Structure,
9,
1165-1181.
|
 |
|
|
|
|
 |
Q.N.Cao,
M.Stubbs,
K.Q.Ngo,
M.Ward,
A.Cunningham,
E.F.Pai,
G.C.Tu,
and
T.Hofmann
(2000).
Penicillopepsin-JT2, a recombinant enzyme from Penicillium janthinellum and the contribution of a hydrogen bond in subsite S3 to k(cat).
|
| |
Protein Sci,
9,
991.
|
 |
|
|
|
|
 |
J.A.Cuff,
and
G.J.Barton
(1999).
Evaluation and improvement of multiple sequence methods for protein secondary structure prediction.
|
| |
Proteins,
34,
508-519.
|
 |
|
|
|
|
 |
J.Yang,
and
J.W.Quail
(1999).
Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
625-630.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.M.Castillo,
K.Mizuguchi,
V.Dhanaraj,
A.Albert,
T.L.Blundell,
and
A.G.Murzin
(1999).
A six-stranded double-psi beta barrel is shared by several protein superfamilies.
|
| |
Structure,
7,
227-236.
|
 |
|
|
|
|
 |
S.Hayward
(1999).
Structural principles governing domain motions in proteins.
|
| |
Proteins,
36,
425-435.
|
 |
|
|
|
|
 |
A.M.Silva,
A.Y.Lee,
S.V.Gulnik,
P.Maier,
J.Collins,
T.N.Bhat,
P.J.Collins,
R.E.Cachau,
K.E.Luker,
I.Y.Gluzman,
S.E.Francis,
A.Oksman,
D.E.Goldberg,
and
J.W.Erickson
(1996).
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
|
| |
Proc Natl Acad Sci U S A,
93,
10034-10039.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Abad-Zapatero,
R.Goldman,
S.W.Muchmore,
C.Hutchins,
K.Stewart,
J.Navaza,
C.D.Payne,
and
T.L.Ray
(1996).
Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.
|
| |
Protein Sci,
5,
640-652.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Rao-Naik,
K.Guruprasad,
B.Batley,
S.Rapundalo,
J.Hill,
T.Blundell,
J.Kay,
and
B.M.Dunn
(1995).
Exploring the binding preferences/specificity in the active site of human cathepsin E.
|
| |
Proteins,
22,
168-181.
|
 |
|
|
|
|
 |
M.Fujinaga,
M.M.Chernaia,
N.I.Tarasova,
S.C.Mosimann,
and
M.N.James
(1995).
Crystal structure of human pepsin and its complex with pepstatin.
|
| |
Protein Sci,
4,
960-972.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Bailey,
and
J.B.Cooper
(1994).
A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
|
| |
Protein Sci,
3,
2129-2143.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Johnson,
N.Srinivasan,
R.Sowdhamini,
and
T.L.Blundell
(1994).
Knowledge-based protein modeling.
|
| |
Crit Rev Biochem Mol Biol,
29,
1.
|
 |
|
|
|
|
 |
E.T.Baldwin,
T.N.Bhat,
S.Gulnik,
M.V.Hosur,
R.C.Sowder,
R.E.Cachau,
J.Collins,
A.M.Silva,
and
J.W.Erickson
(1993).
Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.
|
| |
Proc Natl Acad Sci U S A,
90,
6796-6800.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.S.Abdel-Meguid
(1993).
Inhibitors of aspartyl proteinases.
|
| |
Med Res Rev,
13,
731-778.
|
 |
|
|
|
|
 |
A.Sali,
B.Veerapandian,
J.B.Cooper,
D.S.Moss,
T.Hofmann,
and
T.L.Blundell
(1992).
Domain flexibility in aspartic proteinases.
|
| |
Proteins,
12,
158-170.
|
 |
|
|
|
|
 |
B.Veerapandian,
J.B.Cooper,
A.Sali,
T.L.Blundell,
R.L.Rosati,
B.W.Dominy,
D.B.Damon,
and
D.J.Hoover
(1992).
Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
|
| |
Protein Sci,
1,
322-328.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Suguna,
E.A.Padlan,
R.Bott,
J.Boger,
K.D.Parris,
and
D.R.Davies
(1992).
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
|
| |
Proteins,
13,
195-205.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.D.Walkinshaw
(1992).
Protein targets for structure-based drug design.
|
| |
Med Res Rev,
12,
317-372.
|
 |
|
|
|
|
 |
N.Thanki,
J.K.Rao,
S.I.Foundling,
W.J.Howe,
J.B.Moon,
J.O.Hui,
A.G.Tomasselli,
R.L.Heinrikson,
S.Thaisrivongs,
and
A.Wlodawer
(1992).
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
|
| |
Protein Sci,
1,
1061-1072.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Abad-Zapatero,
T.J.Rydel,
and
J.Erickson
(1990).
Revised 2.3 A structure of porcine pepsin: evidence for a flexible subdomain.
|
| |
Proteins,
8,
62-81.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Beppu
(1990).
Modification of milk-clotting aspartic proteinases by recombinant DNA techniques.
|
| |
Ann N Y Acad Sci,
613,
14-25.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |